ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
Published: 03/11/21, 08:45am (AEST)•4 pages